4.8 Article

Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner

Journal

NATURE COMMUNICATIONS
Volume 8, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-017-00769-0

Keywords

-

Funding

  1. Advanced European Research Council grants [232835]
  2. EU Seventh Framework Program HEALTH [279017]
  3. Israel Science Foundation (ISF)-research grant [991/16]
  4. ISF-Legacy Heritage Biomedical Science Partnership-research grant [1354/15]
  5. Consolidated Anti-Aging Foundation (CAFF)
  6. European Research Council [309788]
  7. Israeli Science Foundation [1782/11]
  8. BLUEPRINT FP7 consortium
  9. Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine
  10. Minerva Stiftung research grant
  11. Israeli Ministry of Science, Technology and Space
  12. David and Fela Shapell Family Foundation
  13. National Human Genome Research Institute Center for Excellence in Genome Science [1P50HG006193]
  14. BMBF
  15. Sobek-Stiftung
  16. DFG [SFB 992, SFB1140]
  17. ERA-Net NEURON initiative NEURO-IFN
  18. Sonderlinie Hochschulmedizin, project neuroinflammation in neurodegeneration
  19. [SFB/TRR167]

Ask authors/readers for more resources

During ageing, microglia acquire a phenotype that may negatively affect brain function. Here we show that ageing microglial phenotype is largely imposed by interferon type I (IFN-I) chronically present in aged brain milieu. Overexpression of IFN-beta in the CNS of adult wild-type mice, but not of mice lacking IFN-I receptor on their microglia, induces an ageing-like transcriptional microglial signature, and impairs cognitive performance. Furthermore, we demonstrate that age-related IFN-I milieu downregulates microglial myocyte-specific enhancer factor 2C (Mef2C). Immune challenge in mice lacking Mef2C in microglia results in an exaggerated microglial response and has an adverse effect on mice behaviour. Overall, our data indicate that the chronic presence of IFN-I in the brain microenvironment, which negatively affects cognitive function, is mediated via modulation of microglial activity. These findings may shed new light on other neurological conditions characterized by elevated IFN-I signalling in the brain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available